NTRB
Price
$7.48
Change
-$0.22 (-2.86%)
Updated
Oct 17 closing price
Capitalization
89.88M
44 days until earnings call
Intraday Buy/Sell Signals
PBIGF
Price
$0.27
Change
-$0.00 (-0.00%)
Updated
Oct 7 closing price
Capitalization
110.23M
Intraday Buy/Sell Signals
Interact to see
Advertisement

NTRB vs PBIGF

Header iconNTRB vs PBIGF Comparison
Open Charts NTRB vs PBIGFBanner chart's image
Nutriband
Price$7.48
Change-$0.22 (-2.86%)
Volume$15.91K
Capitalization89.88M
Paradigm Biopharmaceuticals
Price$0.27
Change-$0.00 (-0.00%)
Volume$5K
Capitalization110.23M
NTRB vs PBIGF Comparison Chart in %
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBIGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTRB vs. PBIGF commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRB is a Hold and PBIGF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (NTRB: $7.48 vs. PBIGF: $0.27)
Brand notoriety: NTRB and PBIGF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTRB: 50% vs. PBIGF: 91%
Market capitalization -- NTRB: $89.88M vs. PBIGF: $110.23M
NTRB [@Biotechnology] is valued at $89.88M. PBIGF’s [@Biotechnology] market capitalization is $110.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRB’s FA Score shows that 0 FA rating(s) are green whilePBIGF’s FA Score has 0 green FA rating(s).

  • NTRB’s FA Score: 0 green, 5 red.
  • PBIGF’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRB is a better buy in the long-term than PBIGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRB’s TA Score shows that 5 TA indicator(s) are bullish while PBIGF’s TA Score has 5 bullish TA indicator(s).

  • NTRB’s TA Score: 5 bullish, 5 bearish.
  • PBIGF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both NTRB and PBIGF are a good buy in the short-term.

Price Growth

NTRB (@Biotechnology) experienced а -0.40% price change this week, while PBIGF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

NTRB is expected to report earnings on Dec 01, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBIGF($110M) has a higher market cap than NTRB($89.9M). NTRB YTD gains are higher at: 58.811 vs. PBIGF (-1.424). NTRB has higher annual earnings (EBITDA): -9.99M vs. PBIGF (-15.46M).
NTRBPBIGFNTRB / PBIGF
Capitalization89.9M110M82%
EBITDA-9.99M-15.46M65%
Gain YTD58.811-1.424-4,130%
P/E RatioN/AN/A-
Revenue2.58MN/A-
Total Cash7MN/A-
Total Debt270KN/A-
FUNDAMENTALS RATINGS
NTRB vs PBIGF: Fundamental Ratings
NTRB
PBIGF
OUTLOOK RATING
1..100
1930
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4637
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRB's Valuation (53) in the null industry is somewhat better than the same rating for PBIGF (86). This means that NTRB’s stock grew somewhat faster than PBIGF’s over the last 12 months.

NTRB's Profit vs Risk Rating (98) in the null industry is in the same range as PBIGF (100). This means that NTRB’s stock grew similarly to PBIGF’s over the last 12 months.

PBIGF's SMR Rating (98) in the null industry is in the same range as NTRB (100). This means that PBIGF’s stock grew similarly to NTRB’s over the last 12 months.

PBIGF's Price Growth Rating (37) in the null industry is in the same range as NTRB (46). This means that PBIGF’s stock grew similarly to NTRB’s over the last 12 months.

PBIGF's P/E Growth Rating (100) in the null industry is in the same range as NTRB (100). This means that PBIGF’s stock grew similarly to NTRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRBPBIGF
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
29%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 4 days ago
39%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
39%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBIGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SILXY24.500.83
+3.48%
Silex Systems Ltd.
MBGAF62.501.43
+2.34%
Mercedes Benz Group AG
RTMVF8.75N/A
N/A
Rightmove Plc
SOSCF0.25N/A
N/A
Deoleo SA
BMNM1.19N/A
N/A
Bimini Capital Management, Inc.

NTRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRB has been loosely correlated with ABSI. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRB jumps, then ABSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
-2.86%
ABSI - NTRB
33%
Loosely correlated
-6.98%
VRAX - NTRB
31%
Poorly correlated
-1.06%
NRIX - NTRB
29%
Poorly correlated
-1.89%
DNLI - NTRB
29%
Poorly correlated
-0.36%
NTLA - NTRB
28%
Poorly correlated
-0.64%
More

PBIGF and

Correlation & Price change

A.I.dvisor tells us that PBIGF and PSTV have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBIGF and PSTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBIGF
1D Price
Change %
PBIGF100%
N/A
PSTV - PBIGF
27%
Poorly correlated
+0.96%
ENLV - PBIGF
26%
Poorly correlated
-3.20%
OXBDF - PBIGF
7%
Poorly correlated
N/A
PTCHF - PBIGF
6%
Poorly correlated
N/A
NTRB - PBIGF
4%
Poorly correlated
-2.86%
More